Bayer Monsanto Roundup

Tommy the Hamburger is here again, and this is Historical Depravity, where we dig up the polished bones of history, crack them open, and show you the rot they tried to dress up as greatness. They called these people kings, visionaries, captains of industry, patriots, reformers, whatever flattering bullshit helped the blood dry faster. I'm here to show you what they actually were. The clean public myth around Monsanto, Bayer, and Roundup goes like this: modern agriculture needed efficient weed control, glyphosate was a scientific breakthrough, regulators reviewed the product, the public was told it was safe when used as directed, and later controversy emerged only because activists, trial lawyers, and confused consumers started panicking over complicated science. In that version, Bayer and Monsanto are basically participants in a hard technical disagreement, maybe a little aggressive in defense of a major product line, but still operating inside the normal boundaries of lawful commerce. That version is horseshit. The uglier record shows a corporation defending a money machine by shaping science, leaning on regulators, attacking criticism, and continuing to market a product under a safety halo while the evidence and internal communications told a much dirtier story. This one matters because it reveals how corporate depravity looks when nobody needs to snarl or twirl a mustache. Nobody has to speak like a comic book villain. They just have to keep the product moving, keep the regulators manageable, keep the science muddy enough, keep the public reassured, keep the lawyers busy, and keep the executives insulated. The whole thing can happen in conference rooms, inboxes, scientific journals, marketing language, and regulatory briefings. That is part of the moral rot. A lot of people still think real evil has to be theatrical. Most of the time it just has a communications team and quarterly targets. Fuck me sideways, that is corporate depravity in its natural habitat. Start with the myth of safety, because that is where the whole machine made its money. Roundup got sold as reliable, modern, effective, and safe enough to be woven into enormous swaths of agricultural and public life. Farmers used it at scale. Landscapers used it. Groundskeepers used it. Homeowners used it. Municipalities used it. Once a product becomes that normalized, the burden of suspicion shifts unfairly onto the people getting hurt. If you are one sick worker facing a corporation whose product sits on shelves everywhere and has been approved by regulators, you look like the anomaly. That is exactly the kind of psychological terrain corporate power loves: ubiquity masquerading as innocence. But ubiquity is not innocence. Ubiquity just means the stakes are bigger when the record starts to crack. And the record did crack. Litigation exposed internal documents. Scientific classification fights intensified. Testimony and discovery showed that Monsanto was not merely disagreeing in good faith with critics. It was deeply invested in controlling the terms of knowledge itself. That includes one of the filthiest recurring mechanisms in modern corporate scandal: ghost management of science. If the literature threatens your product, shape the literature. If independent researchers create risk, discredit them. If regulators might wobble, cultivate relationships. If public trust weakens, wrap yourself in the language of settled expertise while privately worrying about what your own internal discussions already suggest. That is the key mechanism here: not simply selling a dangerous product, but trying to manage the conditions under which danger can be publicly recognized. Monsanto did not just want Roundup sold. It wanted Roundup believed in. It wanted glyphosate defended not merely as useful but as scientifically settled. That is why the internal document trail matters so much. It punctures the public performance layer. It shows executives and employees thinking strategically about studies, papers, messaging, critics, and regulatory leverage in ways that do not read like the behavior of a company serenely confident that truth alone would save it. Once you see that, the myth versus reality split becomes sharp. The myth says regulators approved the product, therefore the issue is basically closed unless someone can produce some absolute final piece of certainty. The reality is that regulatory systems are often built in ways that let industry shape the evidence landscape in the first place. Underfunded agencies lean on industry submitted data. Revolving door cultures blur boundaries. Risk assessment gets narrowed, delayed, proceduralized, and framed within assumptions friendly to existing business models. By the time a product becomes a giant revenue engine, the state is no longer examining some small experimental item. It is examining a political economic ecosystem with donors, lobbying muscle, trade implications, and corporate legal firepower behind it. That matters because people love to treat regulation as magic absolution. "The EPA approved it" becomes a secular version of divine forgiveness. But approval in a compromised, industry shaped, politically pressured system is not proof of moral cleanliness. Sometimes it is proof that power succeeded in writing the conditions of review. If internal records show a company celebrating influence over scientific perception or regulatory process, then the approval itself becomes part of the story rather than the end of it. Now get specific about the human cost without drifting into fake melodrama. People who used Roundup heavily and repeatedly, especially those working in agriculture, landscaping, and groundskeeping, later developed non Hodgkin lymphoma and took the company to court. Many of them were not anti corporate crusaders. They were ordinary working people who trusted the product framework given to them. They used what they were told was standard, legal, safe enough, and professionally normal. Then they got cancer and had to enter the soul grinding world of corporate litigation, where giant firms spend fortunes making injured people prove one molecule, one exposure pathway, one causal chain, one lifetime of trust betrayed. The legal cases mattered not because lawsuits are pure truth machines, but because discovery dragged private records into public light. Juries heard enough to return huge verdicts in favor of plaintiffs. Bayer, after acquiring Monsanto, inherited a toxic archive along with the product line and faced massive settlement exposure. That acquisition is its own little historical joke soaked in acid. A storied German pharmaceutical and chemical company bought what it thought was an agricultural powerhouse and instead strapped a bomb full of litigation, public anger, and reputational rot to its own chest. But even there, do not let the market drama distract you. Falling share value is not the same thing as justice. A corporation taking a financial hit is not the same thing as truth getting properly honored. Because here is the filthy part: financial settlements can coexist perfectly well with moral non accountability. The corporation pays. Executives retire rich. Nobody goes to prison. The product often stays on the market in some form. Public relations language adjusts. Labels change. Claims get massaged. Lawyers negotiate future risk. Shareholders grumble. The system absorbs the scandal and keeps moving. That is why this category exists in the first place. Depravity is not only what happens when a company does harm. It is what happens when the structure for responding to harm is so weak, so monetized, and so impersonal that mass injury can become just another cost model. The scientific controversy around glyphosate has been real, but that phrase gets abused. "There is controversy" can mean honest uncertainty among good faith researchers. It can also mean a corporation successfully bought itself ambiguity by fighting classification, managing literature, and exploiting the public's inability to parse toxicology, epidemiology, exposure pathways, and regulatory language. When the International Agency for Research on Cancer classified glyphosate as probably carcinogenic to humans, the response was not dignified scientific disagreement alone. It was aggressive reputational war. That matters because the style of response tells you something about how much was at stake. If your confidence is clean, you make your case. If your confidence is cornered by billions in revenue and years of branding, you start trying to shape the field on which the argument even happens. And then there is the farming myth, which gets used as an emotional shield. Critics of corporate agrochemicals are often portrayed as naive romantics who do not understand how food systems work. That framing is convenient because it lets a company fuse itself to necessity. If people eat, then the product must be above reproach. If the product helps produce abundance, then criticism becomes vaguely anti modern, anti farmer, anti science. But feeding people does not excuse manipulating science or suppressing inconvenient evidence. Plenty of systems essential to modern life have been run in dangerous, extractive, dishonest ways. Necessity is not exoneration. Sometimes necessity is the exact reason scrutiny should be harder, because more bodies and more land are trapped inside the decision. The broader ecological context matters too. Roundup was not just another product on a shelf. It became central to a farming model built around chemical dependence, monoculture logic, and large scale industrial management of land. When a herbicide gets tied tightly to the architecture of production, criticism of the herbicide threatens more than a single profit stream. It threatens a whole way of organizing agriculture. That creates intense pressure to defend the product beyond what truth can honestly support. The company is no longer just defending one chemical. It is defending an entire system of contracts, crop expectations, seed relationships, farm routines, and market assumptions. That scale helps explain the ferocity of the defense. But scale also enlarges the moral burden. If you know the product is deeply embedded and therefore more politically protected, you have an even stronger duty not to bullshit the public. Instead, the record suggests repeated efforts to preserve legitimacy by shaping what counted as legitimate knowledge. That is the heart of the stink here. Not simple error. Not a single bad memo. Not one clumsy executive statement. A pattern of strategic reputation defense around a product whose public image had to remain cleaner than the archive behind it. The victims are not all courtroom plaintiffs. They include workers who got sick and never had the documentation, money, or stamina to sue. They include families who watched a husband, wife, parent, or sibling spiral into treatment, fear, debt, and exhaustion after years of trusting a supposedly safe product. They include communities soaked in industrial agriculture with little meaningful say over what gets sprayed, marketed, or normalized around them. They include people whose relationship to "choice" is fake from the start because economic survival in an agricultural system often means using the tools the system puts in your hands. Corporate defenders love to talk about informed users. A lot of so called informed users were actually trusting a knowledge environment the company itself spent years contaminating. There is also the legacy problem. Bayer's acquisition of Monsanto led some observers to talk as if the old company had died and the scandal now belonged to history. Convenient nonsense. Corporate mergers do not erase accountability; they redistribute it. Bayer inherited the revenue logic, the legal exposure, the reputational burden, and the obligation to deal honestly with the public. If anything, the merger shows how capitalism routinely converts moral crisis into transactional repositioning. One name gets absorbed into another, the branding changes, the investor story gets rewritten, and the bodies remain exactly where they were. And the polite future version of this file is already trying to write itself. It will say this was a dispute about scientific thresholds and legal standards, that the courts sorted out compensation, that regulators continue to evaluate the evidence, that agriculture moved forward, that lessons were learned. Maybe some lessons were learned. But the deeper record says a corporation built enormous wealth around a product while fighting to protect its aura of safety, even as damaging evidence, internal concern, and plaintiff suffering accumulated. That is not the story of science nobly self correcting in a healthy marketplace. That is the story of power trying to stay ahead of consequence. If you want the mechanism in one filthy line, here it is: Monsanto helped create a world where people exposed to a massively used chemical had to climb over ghostwritten science, regulator cozying, public relations fog, and corporate legal war just to have their suffering taken seriously. That alone should stain the whole myth permanently. You do not get to market safety, manipulate the perception of safety, and then act shocked when people call you bastards after the lawsuits start landing. The myth says Roundup was a lawful agricultural tool caught in overhyped controversy. The truth says Bayer and Monsanto defended a money printing product through influence, narrative control, and scientific contamination while ordinary users paid with fear, illness, and in many cases death. That is why this belongs here. Not because every scientific question on Earth collapses into cartoon certainty, but because the moral pattern is already clear enough: when profit and public health collided, the company fought for profit and tried to make the public call that science. That is the depravity on record. The myth is smaller now, the stink is stronger, and the body count is still the body count. See you in the next grave I have to dig up.